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Abstract
Introduction:Mast cells (MCs) are tissue‐resident immune cells implicated in
antibacterial responses. These include chemokine secretion, degranulation,
and the release of mast cell‐extracellular traps, which are primarily dependent
on reactive oxygen species (ROS) production. Our study investigated whether
human mast cells (hMCs) develop individual response patterns to bacteria
located at different tissue sites: Escherichia coli (gut commensal), Listeria
monocytogenes (foodborne intracellular pathogen), Staphylococcus aureus
(skin commensal and opportunistic pathogen), and Streptococcus pneumoniae
(upper respiratory tract commensal and lung pathogen).
Methods: After live bacteria exposure, hMCs were analyzed by a combined
flow cytometry assay for degranulation, ROS production, DNA externalization,
and for β‐hexosaminidase, chemokine, and prostaglandin release.
Results: L. monocytogenes induced hMC degranulation, IL‐8 and MCP‐1
release coupled with DNA externalization in a novel hMC ROS independent
manner. In contrast, S. pneumoniae caused ROS production without DNA
release and degranulation. E. coli induced low levels of hMC degranulation
combined with interleukin 8 and MCP‐1 secretion and in the absence of
ROS and DNA externalization. Finally, S. aureus induced hMCs pros-
taglandin D2 release and DNA release selectively. Our findings demonstrate
a novel hMC phenomenon of DNA externalization independent of ROS
production. We also showed that ROS production, degranulation, DNA
externalization, and mediator secretion occur as independent immune
reactions in hMCs upon bacterial encounter and that hMCs contribute to
bacterial clearance.
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Conclusions: Thus, hMCs exhibit a highly individualized pattern of
immune response possibly to meet tissue requirements and regulate bacteria
coexistence vs defense.
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1 | INTRODUCTION
Mast cells (MCs) are immune cells that primarily reside
at mucosal surfaces and the skin.1 MC progenitors either
egress from the bone marrow and yolk sac to become
mature MCs at tissue sites or differentiate locally under
the influence of the tissue microenvironment.2‐4 Recent
studies have identified that MCs perform essential func-
tions in response to pathogenic threats.1,5,6 MCs are
strategically positioned to be among the first cells to in-
teract with microbes, such as bacteria, and trigger specific
immune responses against pathogens.5 Furthermore, the
ability of MCs to rapidly release antimicrobial mediators
and proinflammatory molecules has raised interest in the
possibility of their therapeutic modulation for infectious
diseases.7
MCs exhibit a range of defense mechanisms against
bacteria that include the secretion of pro‐ and anti‐
inflammatory mediators which shape both innate and
adaptive immunity.1,5 Such mediators can be released
upon degranulation or following the engagement of the
classical secretory pathway.8 For instance, Mycobacter-
ium tuberculosis and Enterococcus faecalis are associated
with MC cytokine release coupled with degranulation,
whereas commensal bacteria including Bifidobacterium
bifidum, do not induce MC degranulation.9‐11 Mast cell
extracellular trap (MCET) formation is a defense me-
chanism that exposes microbes to inflammatory media-
tors within a mesh of DNA.12,13 MCETs have shown to
contribute to antibacterial immunity, including infections
caused by Listeria monocytogenes, Streptococcus pyogenes,
and E. faecalis.13
Neutrophils form extracellular traps by two mechan-
isms.14,15 The first involves cell death and occurs through
decondensation of the nuclear envelope that is triggered
by the presence of reactive oxygen species (ROS).14,16,17
The second involves DNA release without compromising
cell viability and independently of ROS production.18
However, in MCs, only ROS‐dependent extracellular
traps have been described19,20 with the majority of studies
performed in animal models or human cell lines.19 Fur-
thermore, MCET formation seems to depend on specific
bacterial stimulation. For instance, DNA release is
observed after L. monocytogenes or E. faecalis encounter,
whereas release of DNA is inhibited after M. tuberculosis
exposure.19,21
We hypothesized that different microbes induce
individual patterns of functional response by MCs, in-
cluding degranulation, chemokine secretion, and DNA
release in the presence or absence of ROS production.
We, therefore, assessed human mast cell (hMC) re-
sponses after their encounter with bacteria typically lo-
calized at tissue interfaces: Escherichia coli (gut
commensal), L. monocytogenes (foodborne intracellular
pathogen), Staphylococcus aureus (skin commensal and
opportunistic pathogen), and Streptococcus pneumoniae
(upper respiratory tract commensal and lung pathogen).
We found that L. monocytogenes induced hMC de-
granulation and DNA release in the absence of ROS
production while S. pneumoniae promoted ROS produc-
tion without inducing DNA release and degranulation.
Furthermore, E. coli promoted hMC degranulation in the
absence of DNA or ROS release, whereas S. aureus did
not induce hMCs to degranulate or release DNA but se-
lectively induced MC prostaglandin D2 (PGD2) secretion.
These data suggest that hMCs display specific patterns of
response according to the individual pathogen, involving
degranulation, DNA release, ROS production, and che-
mokine release. These activities occur as independent
reactions. Therefore, our findings suggest that hMCs
respond strategically to individual threats orchestrating
unique immune responses in bacterial defense.
2 | EXPERIMENTAL
PROCEDURES
2.1 | Bacterial strains
Bacterial strains were kept as stocks at −80°C in 15%
glycerol. Before bacteria were used, growth curves were
generated to correlate optical density (OD) with colony‐
forming units (CFUs). E. coli (ATCC 25922) and S. aureus
(ATCC 25923) were cultured in lysogeny broth (Sigma‐
Aldrich, St Louis, MO) and L. monocytogenes (inlA) in
tryptic soy broth (TSB) (Sigma‐Aldrich), at 37°C under
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shaking incubator (200 rpm). S. pneumoniae strain D39
(R6) was cultured in Todd Hewitt Broth and yeast extract
(0.5%) at 37°C without shaking. Bacterial strains were
cultured and harvested at a midpoint of the log‐growth
phase (OD: 0.3‐0.6) for cell stimulations.
2.2 | Human primary MC culture
hMCs were generated as previously described.56 Briefly,
cells were obtained by a positive selection of CD117+
haematopoietic progenitors obtained from buffy coat
blood mononuclear cells by immunomagnetic sorting
(Miltenyi Biotec, Bergisch Gladbach, Germany). Cells were
cultured for 4 weeks in Iscove's modifiied Dulbecco's
medium with GlutaMAX‐I supplemented with 50 µmol/L
β2‐mercaptoethanol, 0.5% bovine serum albumin (BSA), 1%
insulin‐transferrin‐selenium, 100U/mL penicillin, 100 µg/
mL streptomycin (Invitrogen, Carlsbad, CA), ciprofloxacin
(Bio‐world), human interleukin 6 (IL‐6) (50 ng/mL; Pepro-
Tech, Rocky Hill, NJ), human IL‐3 (10 ng/mL; PeproTech),
human stem cell factor (SCF) (100 ng/mL; PeproTech), and
StemRegenin (1 µM; Cayman). Cells were progressively
transferred to culture media containing Iscove's modified
Dulbecco's medium with GlutaMAX‐I supplemented with
50 µmol/L β2‐mercaptoethanol, 0.5% BSA, 1% insulin‐
transferrin‐selenium, 100U/mL penicillin, 100 µg/mL
streptomycin, human IL‐6 (50 ng/mL), and human SCF
(100 ng/mL) for 4 weeks. After 8 to 10 weeks of culture,
cells were tested for purity and maturity, measuring CD117
and FcεRIa expression.
2.3 | hMC infection
hMCs were washed three times to remove antibiotics and
plated at a density of 5 × 105 cells/mL in supplemented
medium without antibiotics. Cells were rested at 37°C in
5% CO2 for 1 hour before infections. Bacteria were cul-
tured and prepared at a multiplicity of infection (MOI) of
25:1 in supplemented medium without antibiotics. MOI
(25:1) was selected by testing different bacterial con-
centrations and choosing the minimum MOI able to in-
duce hMC degranulation. Each bacterial species was
incubated with plated hMCs for 2 hours at 37°C, 5% CO2.
Supplemented media without antibiotics was used to
incubate unstimulated controls.
2.4 | Flow cytometry
For the measurement of ROS, hMCs were pretreated
with dihydrorhodamine 123 (DHR 123) (Thermo Fisher
Scientific) at 1.33 µg/mL for 15minutes before stimula-
tion. To inhibit ROS, 10 µM diphenyleneiodonium
(DPI) (Sigma‐Aldrich) was added 30minutes before
stimulation. Once stimulated with the four different
bacteria, hMCs were washed several times with
phosphate‐buffered saline (PBS) before staining. Cells
were incubated with Fc‐block and stained with fixable
Live/Dead Zombie NIR (BioLegend) according to the
manufacturer's protocol to exclude dead cells with com-
promised cell membranes.
Cells were stained with anti‐human antibodies
CD107a (LAMP‐1) (H4A3; BD BioLegend) and analyzed
by flow cytometry as above. Degranulation was measured
as a percentage of CD107a+ cells.
TO‐PRO‐3 (Invitrogen) was added to cells in the final
15minutes of staining at 1 µM. All dyes and antibodies
were diluted in flow cytometry staining buffer and in-
cubated for 30minutes at 4°C before washing and fixing
cells with 4% paraformaldehyde. Flow cytometric data
were acquired using the BD LSR‐II. Single stain controls
were prepared using compensation beads (OneComp
eBeads; Thermo Fisher Scientific). The postacquisition
data analysis was performed using FlowJo software
(Treestar version 10.4.2).
2.5 | Confocal microscopy
hMCs were washed several times to remove antibiotics
and seeded on a glass slide precoated with poly‐D‐lysine
at a concentration of 5 × 104 hMCs/mL. Cells were left
untreated (control) or incubated with L. monocytogenes
for 16 hours at a MOI 25:1. After stimulation, cells were
washed three times and fixed with formaldehyde 4% for
20 minutes and permeabilized with Triton (0.2%)
(Sigma‐Aldrich). After three washes cells were in-
cubated first with blocking buffer (10% goat serum in
PBS) for 1 hour and then with mouse anti‐human
tryptase antibody (ab2378; Abcam) for 1 hour followed
by 1 hour incubation with goat anti‐mouse antibody
conjugated to Alexa 647 fluorophore (ab150115; Ab-
cam). Cells were washed three times and mounted with
fluoroshield mounting media with 4′,6‐diamidino‐
2‐phenylindole (DAPI; Abcam) to be analyzed by
confocal microscopy. Images were collected at a zoom
factor of 2.58 using a Leica TCS SP8X inverted confocal
microscope equipped with a tuneable white light laser
(WLL), and a diode 405 nm laser, a ×40/0.85 dry ob-
jective, and HyD hybrid detectors. AL647 fluorescence
was excited at 647 nm with WLL laser and detected at
655 to 718 nm on a HyD point detector. DAPI fluores-
cence was excited at 405 nm using the UV laser and
collected pn a HyD detector at 410 to 470 nm. Confocal
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three‐dimensional stacks were acquired with a depth of
8 µm using Leica LASX software. Images stacks were
then processed, sum projected and analyzed using
Fiji.57
2.6 | β‐Hexosaminidase assay
hMCs were stimulated with L. monocytogenes (100 µL,
5 × 105 cells/mL) for 2 hours. After incubation, super-
natants were harvested and cell pellets were lysed in
1% Triton X‐100. β‐Hexosaminidase activity was
measured in supernatants as well as in cell pellets
by adding the substrate p‐nitrophenyl N‐acetyl‐
β‐D‐glucosamine at 1 mmol/L (Sigma‐Aldrich) in
0.05 mol/L citrate buffer (pH 4.5) for 2 hours at 37°C
in a 5% CO2 atmosphere.
56 The reaction was stopped by
using 0.05 mol/L sodium carbonate buffer (pH 10). OD
was measured at 405 nm. Degranulation was assessed
as the percentage release of total β‐hexosaminidase.
2.7 | Measurement of IL‐8, MCP‐1,
and PGD2
After the incubation of hMCs with the different bac-
terial strains, cells were centrifuged, and supernatants
were collected to measure mediator content. Super-
natants were either used immediately after collection
or frozen at −80°C before being analyzed. PGD2 levels
were measured according to the manufacturer's pro-
tocol using enzyme‐linked immunosorbent assay che-
mical Cayman Kit (cat 412012). IL‐8 and MCP‐1 were
quantified by a BD cytometric bead array multiplex kit
following manufacturer's protocol using a FACSVerse
flow cytometer. The analysis was performed using the
FCAP Array Software v3.0.
2.8 | CFU assay
hMCs were stimulated for 2 hours with L. mono-
cytogenes at a MOI 25:1 in 50 µL of cell media. Fifty
microlitres of initial stocks of L. monocytogenes (cor-
responding to MOI of 25:1) were incubated alone for
2 hours. After incubation, 100 µL of cold‐sterile ultra-
pure water was added on the top of cell‐bacterial sus-
pensions to lyse hMCs, and incubated for 10 minutes at
4°C. Then, serial dilutions 1:10 to 1:108 were prepared
in PBS, and 10 µL of each dilution was plated on TSB
agar (Sigma‐Aldrich) in five replicates (50 µL in total).
CFUs were counted after 1 to 3 days (3 days final
count).
2.9 | Statistical analysis
Data were analyzed using the GraphPad Prism 7.0
(GraphPad Software, San Diego, CA). All samples were
processed in triplicates. Comparison between more than
two groups was achieved using one‐way analysis of var-
iance correcting for Tukey's multiple comparisons and
comparisons between two groups were performed by
unpaired t test. Correlations were calculated using
Spearman R (R2). P values of .05 or less were considered
to be statistically significant.
3 | RESULTS
3.1 | L. monocytogenes and E. coli induce
hMC degranulation
Several bacteria are known to trigger MC degranula-
tion, whereas nonpathogenic gut resident strains, in-
cluding Lactobacillus spp. appear to inhibit this
process.22 We sought to characterize further and
compare MC degranulation as a defense mechanism
against bacteria encountered at different tissue
sites. hMCs derived from peripheral blood precursors
that had the phenotypic and functional properties of
mature hMCs (Figures 1A and SA) were stimulated
with an intracellular intestinal pathogen L. mono-
cytogenes, an intestinal commensal E. coli, a skin
commensal S. aureus, or a lung commensal S. pneu-
moniae intending to detect differences in induced
hMC degranulation.
To assess hMC degranulation following incubation
with bacteria at a MOI of 25:1, we measured: (a) surface
expression of CD107a (Figure 1B,C)23 using flow cyto-
metry; and (b) granule compound release by means of
β‐hexosaminidase secretion (Figure 1D). Unstimulated
hMCs were used as a negative control.
The level of degranulation (CD107a+ hMCs;
β‐hexosaminidase release) was highest in hMCs in-
cubated with L. monocytogenes (45.8%; 36.1%), compared
with E. coli (9.8%; 26.1%), S. pneumoniae (3.7%; 2.9%),
and S. aureus (3.7%; 6.4%) exposure (Figure 1B‐D). Both
S. aureus and S. pneumoniae showed no significant
effect on hMC degranulation (1.9%) (Figure 1B‐D).
Furthermore, the percentage of β‐hexosaminidase
release was found to correlate (rs = 0.82) with the
CD107a hMC expression (Figure SB). Thus, hMCs exhibit
a diverse degranulation response to different bacterial
strains, and obligate pathogens invading gut, such
as L. monocytogenes, may promote higher levels of MCs
degranulation compared with opportunistic pathogens
resident in skin or lung.
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FIGURE 1 hMCs show different patterns of degranulation in response to different bacterial strains. hMCs were stimulated with either
Listeria monocytogenes (L. monocytogenes), Escherichia coli (E. coli), Streptococcus pneumoniae (S. pneumoniae), or Staphylococcus aureus
(S. aureus) at a MOI of 25:1 or media for 2 hours. A, Single live cells were selected by the side scatter (SSC‐A), forward scatter (FSC‐A). Live vs
dead cells were discriminated by Zombie NIR staining. CD107a antibody and TO‐PRO‐3 and DHR dyes were used to investigate degranulation,
DNA secretion and ROS production, respectively. B, CD107a flow cytometry representative of four independent experiments shows MC
degranulation upon bacterial stimulation. C, Percentage of CD107a expressing cells (D) and % of β‐hexosaminidase release upon bacterial
stimulation. Graphs (C) and (D) are a representative of four independent experiments performed each with three replicates. Statistical analysis
was performed using two‐way ANOVA and Tukey's multiple comparisons test (****P< .0001, ***P< .001, **P< .01). ANOVA, analysis of
variance; DHR, dihydrorhodamine; hMC, human mast cell; MC, mast cell; MOI, multiplicity of infection; ROS, reactive oxygen species
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3.2 | Selective bacterial stimulation
induces hMCs to release IL‐8, MCP‐1,
and PGD2
Among the studied bacteria, only L. monocytogenes and
E. coli induced hMC degranulation. However, hMCs
also release a wide variety of proinflammatory mediators
independently of degranulation in a stimuli‐specific
manner.8 Such proinflammatory molecules allow hMCs
to orchestrate the response of other immune cells to
bacteria.24 We hypothesized that bacteria encountered at
different tissue sites induce a specific pattern of cytokine
production independently of degranulation. To test this
hypothesis, hMC mediators (MCP‐1, IL‐8, and PGD2)
were quantified in culture supernatants after stimulation
with bacteria.
L. monocytogenes, which induced the strongest
degranulation among the studied bacteria (Figure 1B‐D)
significantly promoted the release of proinflammatory
mediators (mean chemokine release) including IL‐8
(314.2 pg/mL) and MCP‐1 (1663 pg/mL) secretion com-
pared with unstimulated cells (Figure 2A). E. coli,
induced a relatively low degranulation (Figure 1B‐D)
and IL‐8 (61.2 pg/mL) and MCP‐1 (553.9 pg/mL) secre-
tion (Figure 2A) compared with L. monocytogenes. The
levels of hMC mediator secretion upon S. aureus and
S. pneumoniae exposure were similar to the unstimulated
controls. The release of granulocyte‐macrophage colony‐
stimulating factor, IL‐10 and IL‐1β was tested but was
undetectable (data not shown).
L. monocytogenes, S. aureus, and E. coli significantly
induced PGD2 secretion with mean levels of 65.9,
27.4, and 62.1 ng/mL, respectively. No significant
PGD2 release compared with unstimulated controls
(0.6 ng/mL) was observed upon S. pneumoniae stimu-
lation (9 ng/mL) (Figure 2B). Taken together, our
findings suggest that mediator release is both bacterial
specific and independent of degranulation.
3.3 | hMCs contribute to
L. monocytogenes killing
hMCs produce high levels of extracellular DNA, IL‐8,
MCP‐1, and PGD2 upon L. monocytogenes stimulation.
Different studies have shown that cytoplasmic content
exposed in DNA traps is able to kill pathogens.12,13,25
Therefore, we aimed to investigate whether the hMC
mediator secretion induced by L. monocytogenes infection
affects bacterial survival. After hMCs incubation with
L. monocytogenes, bacterial numbers were determined
by CFUs. As observed in Figure 2C, 55% less CFUs
were observed in the cultures containing hMCs
compared with the ones of bacteria alone. These
findings suggest that hMC responses to L. monocytogenes
contribute to bacterial clearance.
3.4 | hMCs display a distinctive pattern
of degranulation, DNA secretion, and ROS
production upon bacterial encounter
hMCs contribute to bacterial containment through the
formation of extracellular traps. Current literature reports
MCET formation upon MC exposure to L. monocytogenes,
S. aureus, S. pyogenes, and M. tuberculosis.19,20 However,
FIGURE 2 Bacterial stimulation induces selective IL‐8,
MCP‐1, and prostaglandin D2 secretion and hMC‐mediated
bacterial clearance. hMCs were stimulated with either Listeria
monocytogenes (L. monocytogenes), Escherichia coli (E. coli),
Streptococcus pneumoniae (S. pneumoniae), or Staphylococcus
aureus (S. aureus) at a MOI of 25:1 or media control for 2 hours.
Supernatants were collected for measurement of (A) IL‐8 and
MCP‐1 and (B) prostaglandin D2‐MOX concentrations by a
multiplex cytometric bead array. C, To analyze bacterial survival,
hMCs were stimulated with L. monocytogenes at a MOI of 25:1 for
2 hours. Bacterial inoculums were used as control bacterial
concentration (100%) and treated equal to stimulated hMCs. After
incubation, samples were lysed, serial dilutions were prepared,
cultured in agar plates, and CFUs were counted. Data shown are
the mean of three replicates of a representative experiment out of
four independent experiments performed. Statistical analysis was
performed using unpaired t test (C) and two‐way ANOVA and
Tukey's multiple comparisons test (A,B) (****P< .0001, ***P< .001,
**P< .01, *P< .1). ANOVA, analysis of variance; CFU, colony‐
forming unit; hMC, human mast cell; IL‐8, interleukin 8; MOI,
multiplicity of infection
6 | GARCIA‐RODRIGUEZ ET AL.
DNA secretion, reflective of MCET formation, has been
reported as dependent on ROS production. We have
shown that the complex nature of hMC responses
allows degranulation and mediator secretion to be discrete
and independent processes. Thus, we hypothesized that
bacterial‐induced DNA release might occur in a bacterial
specific and ROS independent manner, as in neutrophils.18
To investigate this idea, hMCs were incubated with
L. monocytogenes, E. coli, S. pneumoniae, or S. aureus for
2 hours and stained with CD107a antibodies, TO‐PRO‐3
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and DHR dyes to assess degranulation, DNA release, and
ROS production, respectively.
Different levels of DNA externalization (mean %TO‐
PRO‐3+ cells), ROS release (mean %DHR+ cells), and
degranulation (mean %CD107a+ cells) were observed
among stimulated cells (Figure 3A‐C). L. monocytogenes
induced in hMCs a significantly higher DNA ex-
ternalization (98.4%) compared with unstimulated con-
trols (4.9%; Figure 3B). L. monocytogenes‐dependent
degranulation and DNA secretion occurred in the
absence of ROS production (Figure 3A,B). E. coli induced
lower degranulation compared to L. monocytogenes
(Figure 1) occurring in the absence of DNA secretion
and ROS production (Figure 3A,B). In contrast, ROS
production upon S. pneumoniae stimulation (73.5%)
was significantly higher compared with unstimulated
controls (0.6%). Interestingly, despite the high numbers
of hMCs producing ROS after S. pneumoniae stimulation,
only 16% of hMCs released DNA and in the absence
of degranulation (Figure 3A,B). In addition, S. aureus
significantly induced DNA externalization (12.9%) in
hMCs compared with unstimulated controls occurring
in the absence of ROS production and degranulation
(Figure 3A,B).
To investigate the association of hMC degranulation
with DNA secretion and ROS production after exposure
to the four studied bacteria, we carried out a part of
a whole analysis correlating degranulation (CD107a+),
ROS production (DHR+), and extracellular DNA release
(TO‐PRO‐3+) in stimulated hMCs (Figure 3C). Upon
L. monocytogenes exposure, 40% of hMCs were CD107a+,
DHR−, and TO‐PRO‐3+ (Figure 3C, green) and 60% were
CD107a−, DHR−, and TO‐PRO‐3+ (Figure 3C, pink). This
indicates that although most of the L. monocytogenes‐
stimulated cells secreted DNA (98%), only 60% were
associated with degranulation and none of the total
population produced ROS. In contrast, degranulated cells
stimulated by E. coli were not associated with DNA and
ROS production. Furthermore, after S. pneumoniae
encounter, 67% of cells produced ROS in the absence of
DNA and degranulation. In addition, only 4% of the total
DNA released (17%) after S. pneumoniae exposure was
associated with ROS. Finally, after S. aureus stimulation,
DNA release and degranulation were not found to be
linked.
To further prove that DNA release can occur in
hMCs independently from ROS secretion, hMCs
exposure to L. monocytogenes was preceded by in-
cubation with DPI, a ROS inhibitor.26 TO‐PRO‐3 and
DHR were measured by flow cytometry (Figure 3D,E).
hMCs infection with S. pneumoniae was used as
a positive control for DPI‐induced ROS inhibition
(Figure 3E). As shown in Figure 3D, ROS inhibition
did not affect DNA release.
Altogether, these findings suggest that in hMCs the
release of DNA, ROS production, and degranulation
can occur independently and under the control of distinct
bacterial‐cell interaction.
3.5 | L. monocytogenes infection affects
hMC viability
We showed that L. monocytogenes induces an extensive
release of DNA (assessed by TO‐PRO‐3) from hMCs
(Figure 3). To investigate whether bacterial infection
affects cell viability, hMCs were incubated with the
four bacterial strains and cell viability (mean Zombie−
cells) was assessed by flow cytometry. While E. coli,
S. pneumoniae, and S. aureus, did not affect hMC
survival, L. monocytogenes reduced cell viability (Zom-
bie− cells, 70.2%) (Figures 4A and SC). Furthermore,
most of the live cells (Zombie−) were TO‐PRO‐3+ (66.8%).
However, we observed that 28% of hMCs releasing DNA
FIGURE 3 The MC pattern of degranulation, DNA secretion, and ROS production is bacteria specific. hMCs were stimulated with
either Listeria monocytogenes (L. monocytogenes), Escherichia coli (E. coli), Streptococcus pneumoniae (S. pneumoniae), or Staphylococcus
aureus (S. aureus) at a MOI of 25:1 or media controls for 2 hours. After stimulation, cells were stained with TO‐PRO‐3 (DNA, DNA
secretion), DHR (ROS, ROS production), and CD107a (DEGRA, degranulation) and analyzed by flow cytometry. A, Flow cytometry
data show one representative plot. B, Percentage of TO‐PRO‐3+, DHR+, and CD107a+ cells after bacterial stimulations. Each graph shows
the mean of three replicates of a representative experiment out of four independent experiments performed. Statistical analysis was
performed using two‐way ANOVA and Tukey's multiple comparisons tests (****P< .0001, ***P< .001, **P< .01, *P< .1). C, Frequency
of CD107a+/− (DEGRA, black), DHR+/− (ROS, red) and TO‐PRO‐3+/− (DNA, blue) cells upon bacterial exposure. Data for each condition
(L. monocytogenes, E. coli, S. pneumoniae, S. aureus, and media control) was taken from the mean (n = 3) of a representative experiment of
four independent experiments. To investigate DNA release is ROS independent, hMCs were incubated with DPI to inhibit ROS production,
and stimulated then with L. monocytogenes and stained with TO‐PRO‐3. A, Values were normalized to the TO‐PRO‐3 positive control
hMCs challenged with L. monocytogenes in the absence of DPI. B, The inhibitory effect of DPI on ROS production was controlled in hMCs
stimulated with S. pneumonia, and stained with DHR. Data show values normalized to hMC incubated with S. pneumonia without
DPI. ANOVA, analysis of variance; DHR, dihydrorhodamine; DPI, diphenyleneiodonium; hMC, human mast cell; MC, mast cell, MOI,
multiplicity of infection; ROS, reactive oxygen species
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(TO‐PRO‐3+) were positive for the cell death marker
(Zombie+) (Figure 4B). Thus, these findings indicate that
DNA release induced by L. monocytogenes occurs in live
hMCs, and that this phenomenon is associated with a
low level of cell death.
3.6 | Infection of hMCs with
L. monocytogenes induces the formation
of extracellular traps
MC lines and rodent MCs have been shown to release
DNA using microscopy techniques.19‐21,27 To investigate
whether the release of extracellular DNA in hMCs was
associated with the formation of extracellular traps, cells
were incubated with L. monocytogenes for 16 hours and
colocalization of extracellular DNA (DAPI staining) and
MC granule content release (tryptase staining) was ana-
lyzed by confocal microscopy. As shown in Figure 5,
L. monocytogenes‐stimulated hMCs showed externalized
DNA (Figure 5A) that colocalized with tryptase com-
pared with unstimulated controls (Figure 5B). These
data indicate that hMCs exposed to L. monocytogenes
form extracellular traps.
4 | DISCUSSION
The present study demonstrates that hMCs employ
distinctive patterns of responses to L. monocytogenes,
E. coli, S. pneumoniae, and S. aureus. The hMC immune
reactions include DNA externalization, ROS production,
degranulation and chemokine, and PGD2 secretion.
Differences between hMCs and rodent MCs or MC
lines have been described.28 Furthermore, since hMCs
are tissue‐resident cells, their location and relative low
numbers makes it difficult to isolate and use them
for complex experimental settings. Therefore, blood‐
differentiated mature hMCs were used in this study as an
alternative useful tool to tissue cells.
The release of extracellular traps is well characterized
in neutrophils as a mesh of histones, antimicrobial
peptides and granular proteins to trap and kill
bacteria.14 Using a flow cytometry assay, we have
found that L. monocytogenes and S. aureus induce DNA
externalization without intracellular ROS production.
This mechanism is novel in hMCs, which have so far
been described to form extracellular traps (ETs) while
undergoing NADPH‐dependent cell death.19‐21 In neu-
trophils, the latter type of ET production is termed “sui-
cidal NETosis” as it leads to cell death.14 However, in
response to S. aureus Pilsczek et al18 described a second
ROS independent mechanism in neutrophils called “vital
NETosis” in which the release of DNA occurs by fusion of
DNA‐containing vesicles with the plasma membrane.18 A
similar mechanism of “vital MCETosis” might occur in
ROS‐negative, DNA positive hMCs exposed to L. mono-
cytogenes, S. aureus, and E. coli that would be in line with
the long‐lived, tissue‐resident nature of hMCs.29 Our
study demonstrated that L. monoctyogenes induces
MCETs and a low level of cell death. Therefore, we
FIGURE 4 L. monocytogenes affects human mast cell (hMC)
viability. hMC viability upon bacterial infection was measured after
L. monocytogenes stimulation, cells were stained with (A) Zombie
NIR (live cells) and (B) TO‐PRO‐3 (DNA releasing cells). Flow
cytometry plots show one replicate of a representative experiment
out of three independent experiments. Graph shows the mean
of three replicates of a representative experiment out of three
independent experiments performed. Statistical analysis was
performed using unpaired t test (**P< .01)
FIGURE 5 L. monocytogenes induces extracellular trap
formation. Human mast cells were seeded in a glass slide precoated
with poly‐D‐lysine. Cells were settled and stimulated with
L. monocytogenes or media (unstimulated control) for 16 hours.
After incubation cells were washed and stained for extracellular
DNA using 4′,6‐diamidino‐2‐phenylindole and for tryptase with
anti‐human tryptase antibody conjugated to Alexa 647 fluorophore.
Slides were analyzed by confocal microscopy. A, L. monocytogenes‐
stimulated cells and (B) unstimulated controls were stained and
merged to visualize extracellular and intracellular tryptase‐DNA
colocalization, respectively
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suggest that, upon L. monoctyogenes encounter, hMCs
exhibit early “suicidal MCETosis” as well as early “vital‐
DNA release,” and following this, late (after 16 hours)
DNA externalization and web‐like structures formation,
late suicidal MCETosis. A similar process was described
in neutrophils,18 where a ROS independent vital‐NETosis
induces rapid DNA release (5‐60minutes) without com-
promising the cell membrane.18 In MCs, the rapid release
of DNA may contribute for the release of inflammatory
mediators and bacterial clearance.
The pore‐forming toxin, listeriolysin O, is a primary
virulence factor of L. monocytogenes that conveys pha-
gocytosis avoidance and allows bacteria to reside in-
tracellularly.30 Previous studies have shown that this
toxin is necessary to trigger hMCs responses such as
degranulation and mediator secretion.31 Although this
needs to be confirmed, this toxin in addition to inducing
tryptase secretion may be involved in the process of
DNA release and MCET formation. In our study,
L. monocytogenes, the only obligate pathogen tested,
which also resides intracellularly, induced a robust MC
response with active DNA release. In line with the extent
of DNA release measured in our assay, Campillo‐Navarro
et al19 observed a peak of DNA release in a hMC line
after 3 hours exposure to L. monocytogenes by fluorescent
microscopy. Primary hMCs generally respond faster
to external triggers.32,33 However, by microscopy, we
demonstrated that L. monocytogenes induced DNA ex-
ternalization colocalized with granular content (tryptase)
only after 16 hours incubation. In contrast, flow cyto-
metry demonstrated an early DNA externalization after
only 2 hours incubation. Thus flow cytometry may pro-
vide a sensitive and more suitable detection technique for
quantifying DNA release at early stages upon infection.
The rapid and robust release of DNA observed may
serve MCs, which display low phagocytic capacity,34,35
the ability to inhibit bacterial multiplication alongside
MC degranulation together with chemokine and cytokine
secretion which is vital in driving neutrophil recruitment
during L. monocytogenes infection, as suggested by
Gekara and Weiss.36 In our study, we confirmed that
L. monocytogenes is killed by hMCs, while promoting
hMC degranulation and the release of IL‐8 and MCP‐1,
thus supporting the role of MC in the inflammatory
process of cellular recruitment and bacterial clearance.
In previous studies, minimal degranulation was
observed after exposing murine bone marrow–derived
mast cells for 2 hours to L. monocytogenes (MOI: 10:1).
Furthermore, a peak of MCP‐1 secretion was shown
at 2 hours using a MOI of 100:1.31 In contrast, our find-
ings showed a stronger hMC degranulation after
L. monocytogenes exposure and similar concentrations
of secreted MCP‐1 at a MOI of 25:1. This suggests that
hMCs are more sensitive to pathogenic threats compared
with mouse MCs.
MCs appear to exhibit a different range of functional
responses toward commensal bacteria. Magerl et al22
demonstrated in vitro that high doses (1 × 109 CFU/mL)
of a probiotic E. coli strain could inhibit mouse MC
degranulation. Furthermore, gut resident probiotic
bacterial strains such as Lactobacillus rhamnosus and
Bifidobacterium animalis downregulate degranulation‐
inducing receptors.37 While degranulation may be re-
dundant in the MC response to E. coli, the release of
proinflammatory mediators, including tumor necrosis
factor (TNF), IL‐8,38‐40 and leukotrienes appear pivotal
for E. coli infection recovery.41 In our study, E. coli strain
ATCC 25922, originally a clinical strain was not asso-
ciated with an inhibitory effect on degranulation, perhaps
reflecting differences in the E. coli strains used by our-
selves and Magerl.22 However, it induced a lower level
of degranulation compared with L. monocytogenes. IL‐8
and MCP‐1 (CCL2) and PGD2 are important chemoat-
tractants that recruit inflammatory cells in defense to
pathogens.42 We showed the release of IL‐8, MCP‐1, and
PGD2. This suggests hMCs may strategically contribute
to cell recruitment during an acute infection against
pathogenic bacteria by the selective release of chemo-
kines while avoiding an enhanced inflammatory reaction
caused by uncontrolled hMC degranulation upon non-
pathogenic bacterial encounter. Furthermore, E. coli
virulence factors activate MC responses. These include
the type 1 fimbriae, which induces the release of TNF,
IL‐6, and eicosanoids,43 and the pore‐forming toxin
α‐hemolysin, which has been described to contribute to
MC degranulation and IL‐8 release.38 Thus, these viru-
lence factors may be involved in the chemokine secre-
tion, degranulation, and PGD2 release observed in our
hMC cultures.
S. pneumoniae is a Gram‐positive coccus that resides
within the upper respiratory tract but can cause invasive
sinopulmonary infection by its outgrowth.44 Pneumolysin
is a crucial virulent factor of S. pneumoniae.45 Cruse
et al46 observed that pneumolysin together with H2O2 are
virulent factors causing hMC cytotoxicity. Our data de-
monstrated that after 2 hours of hMC stimulation, S.
pneumoniae was capable of inducing significant amounts
of ROS, while cell viability was not affected. However,
we cannot exclude that hMC cytotoxicity occurs at later
time points.
The unencapsulated S. pneumoniae strain D39 (R6)
used in the present study serves to understand the
dynamics of colonization in mucosal tissue where
hMC resides. Previous studies have shown that MC de-
granulation after encountering encapsulated S. pneumo-
niae only occurs with high bacterial concentrations.46‐48
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For instance, Barbuti et al47 observed MC degranulation
using a MOI of 250:1 with a peak of histamine release
after 4 hours. Our study demonstrated that S. pneumo-
niae does not cause either degranulation or chemokine
secretion in primary hMCs at a MOI of 25:1. This lack
of MC response against S. pneumoniae may reflect
differences in the capsule status of the strains used, but
interestingly this lack of MC response seen in our studies
has also been observed in the in vivo infection49 where
van den Boogaard et al49 showed prolonged survival of
MC‐deficient mice compared with wild‐type (WT) mice
during S. pneumoniae infection. Furthermore, the in-
hibition of MC degranulation in WT mice did not
change the disease outcome.49 This suggests that during
S. pneumoniae infection, MCs play a detrimental role
for the host, which is independent of degranulation.
Finally, we have investigated hMC responses against
S. aureus, which is a Gram‐positive coccus colonizing the
skin and gut.50 The in vivo activity of S. aureus on MCs
appears diverse and remains controversial and in part
may reflect that different S. aureus strains have been used
in a number of different studies. S. aureus has been
shown to induce bone marrow–derived murine MCs to
release TNF‐α and tryptase.51,52 The latter phenomenon
also occurs in skin MCs during in vivo infection followed
by bacteria internalization.51 In a murine peritoneal
S. aureus infection model, MCs have no impact on the
outcome of the disease.53 However, in a lung S. aureus
infection model, MCs display a protective role.54 In
contrast, our data show a lack of hMC degranulation in
response to S. aureus, but rather a selective release of a
major proinflammatory mediator, PGD2.55 Therefore,
the in‐vivo mouse data cited above demonstrates that the
nature of the tissue influences the type of MC response
raised to commensals and pathogens, and our data
indicate that hMCs cells exploit differential strategies in
antibacterial responses and commensalism compared
with their mouse counterparts.
In summary, hMCs control bacterial infections via
different mechanisms that are stimulus‐specific and
include degranulation, cytokine and chemokine secre-
tion, and ET formation. Our data demonstrated that
while L. monocytogenes robustly induces degranulation
independent of ROS production, S. pneumoniae
releases ROS with negligible DNA externalization.
Furthermore, E. coli exhibited a relatively low level of
degranulation with higher release of proinflammatory
mediators, whereas S. aureus selectively released
PGD2 without promoting any degranulation. Thus,
the present study not only underlines how versatile
and plastic hMCs operate in antibacterial immune re-
sponses but also how adaptable MCs are in
their interaction with commensals.
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